DEFERASIROX USE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH β-THALASSEMIA MAJOR: Preliminary Results

Author: Unal Sule   Kuskonmaz Baris   Hazirolan Tuncay   Eldem Gonca   Aytac Selin   Cetin Mualla   Uckan Duygu   Gumruk Fatma  

Publisher: Informa Healthcare

ISSN: 1521-0669

Source: Pediatric Hematology and Oncology, Vol.27, Iss.6, 2010-08, pp. : 482-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content